Horizon Europe: Health

Next generation advanced therapies to treat highly prevalent and high burden diseases with unmet medical needs

Deadline: 21 september 2021

Advanced therapies are not being implemented because of the lack of research on their safety, immunity, cost-effectiveness etc. This call aims to support the preclinical research on these advanced therapies.

Proposals must contribute to all following outcomes:

  • The use of assays is implemented to assess efficiency, delivery, safety, potency etc.
  • New advanced therapies are tested on gene editing or RNA.

Call ID: HORIZON-HLTH-2021-TOOL-06-02

Financiert projecten binnen:

De officiële aanmelding van Horizon Europe: Health

Contact betreffende subsidie van Horizon Europe: Health

Past deze aanmelding bij uw project? We nemen graag contact met u op voor een vrijblijvend advies over de Horizon Europe: Health subsidiemogelijkheden voor uw project.

Alle aanmeldingen van Horizon Europe: Health

Over Horizon Europe: Health

The Horizon Europe: Health Cluster supports research and innovation that contribute to Europe’s recovery and resilience from the global pandemic as well as projects aimed at the cancer care pathway. There are six specific areas of impact contained in the Health Cluster:

  • Staying healthy in a rapidly changing society
  • Living and working in a health-promoting environment
  • Tackling diseases and reducing disease burden
  • Ensuring access to innovative, sustainable and high-quality health care
  • Unlocking the full potential of new tools, technologies and digital solutions for a healthy society
  • Maintaining an innovative, sustainable and globally competitive health-related industry
Meer over de subsidies